National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Prucalopride (Resolor®) for the symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief.

Rapid Review

Commenced Completed Outcome
17/01/2011 March 2011 Full Pharmacoeconomic Evaluation not Recommended.

Prucalopride (Resolor®) is to be reimbursed under the Community Drugs Schemes subject to conditions.